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Discussion
Dr Davis C. Drinkwater (Nashville, Tenn). I very much en-
joyed the article. One point and question come to mind with this
potential technique. Myocardial distention on a ventricle might be
injurious, particularly in an immature heart under fibrillatory ar-
rest. Therefore, if you have a left-sided valve problem, presumably
you are going to try to open that valve. Are you concerned about
creating an insufficient valve under those conditions as opposed to
the crossclamp condition in terms of less precise pressure control
and causing left ventricular distention with possible poor myocar-
dial protection?
Dr Malhotra. You are always worried about distention when
using fibrillation, but if you can restore the patterns of blood flow,
you can avoid the potentially adverse effects of hypothermia. From
a practical standpoint, fibrillation is easier to accomplish in the
fetus than hypothermic cardioplegic arrest.
Dr John E. Mayer, Jr (Boston, Mass). I am sure this is not an
easy model to work with, and it has got to be a real challenge to
get these things to work. There are a few interesting questions that
sort of came up in my own mind, one of which is with the fetal PO2
values being quite a bit lower than they are in postnatal life, how
do you think that the effect of using a Langendorf preparation,
where you almost certainly have hyperoxic conditions, might yield
results that would be at variance with what you might see in a fetal
myocardium?
Dr Malhotra. That is excellent point. We actually did take that
into account, and we were very sensitive to the effects of hyper-
oxia. We did, at periodic intervals, perform blood gas analysis of
the perfusate and attempted to keep the PO2 between 30 and 40 mm
Hg.
Dr Mayer. Okay. And then the second issue, which is related:
have you considered using a blood prime or a blood perfusate in
your circuit rather than the crystalloid Langendorf type prepara-
tion?
Dr Malhotra. Actually, when we first thought about designing
the model, we wanted to use a blood prime, but, as you know, the
difficulty was in having enough fetal blood to use. Because of the
differences in fetal and adult hemoglobin, we did not want to use
pooled blood from adults.
Dr Frank W. Sellke (Boston, Mass). I agree, this is an out-
standing study; it is extremely novel and innovative. You only
gave one dose of cardioplegia crystalloid solution. Do you think
that provided optimal protection?
How could you modify the cardioplegic solution to take into
consideration the immature nature of the calcium-handling system
within the immature myocardium to provide optimal protection?
Dr Malhotra. Repeat your first question, please.
Dr Sellke. You gave one dose of the crystalloid cardioplegia.
Dr Malhotra. Right. That is one of the things we want to look
at in the future. Dosing of cardioplegia in neonates varies from
institution to institution, but from discussions with the perfusion-
ists and the staff at the University of California, we were comfort-
able with using one dose for a 30-minute arrest period. Of course,
in the future, we can look at multiple dosing. In terms of modifying
cardioplegia to account for the immaturity of fetal calcium regu-
lation, we presented our studies at the American Heart meeting this
past November, in which we altered the calcium concentration in
the cardioplegic solutions, and found that there is a profound
influence of calcium cardioplegic concentration.
Dr Erik A. Beyer (Cleveland, Ohio). I had a question about the
Langendorf model. You seem to suspend the heart from the aorta
and the pulmonary artery, is that correct?
Dr Malhotra. From the SVC and the aorta.
Dr Beyer. Does that have any effect on the hemodynamic
measurements that you have? Did you try to rest the heart from its
apex or posteriorly from the atrium to more simulate a more
normal situation?
Dr Malhotra. We went through a number of iterations with
this model, and initially we had started out with suspending or
having it rest on a platform, but we graduated to this and did not
find any difference in hemodynamic performance.
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